1.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SBG-2-03, EudraCT-number: 2008-002340-42, NCT00790322
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SBG-2-01, NCT00533364
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000378186, MSKCC-04050, NCT00089258
|
|
4.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI
Protocol IDs: MSKCC-01075, NCI-G02-2067, NCT00037011
|
|
5.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: MSKCC-03095, NCT00087009
|
|
6.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000554434, MSKCC-05073, 05-073, NCT00492167
|
|
7.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SBG-2-02, NCT00533728
|
|
8.
|
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 1 and over
Sponsor: NCI
Protocol IDs: 090109, 09-C-0109, NCT00923832
|
Mobile | Español
